And that median across all the individual ABBV stock predictions was: $115.0 as of 2021-01-03. The high price target for ABBV is $128.00 and the low price target for ABBV is $95.00. The Ratings Breakdown table uses Zacks' brokerage recommendations. Please log in to your account or sign up in order to add this asset to your watchlist. by Ken Faulkenberry | Dividend Aristocrats. It is a trending stock that is worth watching. AbbVie Inc. is a research based biopharmaceutical company engaged in discovery, development, manufacture and sale of a range of pharmaceutical products. Abbvie stock rose 1% a day after the announcement and is up almost 6% over the past week. Learn More Log in to see them here or sign up to get started. If a stock is valued near, or slightly below the market average, research has shown that the market expects the stock’s dividend to increase. Get short term trading ideas from the MarketBeat Idea Engine. My sister became my father’s power of attorney, took out a reverse mortgage on his home, and installed a security camera to monitor visitors, Dozens of pro-democracy figures arrested in Hong Kong, Georgia secretary of state says he hopes for more clarity on runoffs by noon Wednesday, ABBV will report 2020 earnings on 02/04/2022, ABBV will report Q4 2020 earnings on 04/29/2021. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock. All analysis relies on publicly available financial information. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). New. S&P. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Abbvie share forecasts, stock quote and buy / sell signals below. ABBV DMA charts and information, presented by ... Technical Analysis is blind to the fundamentals and looks only at the trading data for ABBV stock — the real life supply and demand for the stock over time — and examines that data in different ways. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 Export data to Excel for your own analysis. Receive a free world-class investing education from MarketBeat. Since then, ABBV stock has risen by 330.49%, with an average of 41.31% per year. There are currently no items in this Watchlist. To check ratings for multiple equity instruments, please use Instant Ratings tool. Today it was reported that the Senior Vice-President Operations of AbbVie (ABBV – Research Report), Jeffrey Ryan Stewart, exercised options to sell 25,290 ABBV shares for a total transaction value of $2.66M.See today’s analyst top recommended stocks >> Based on AbbVie’s latest earnings report for the quarter ending September 30, the company posted quarterly revenue of $12.9 … Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 5.63%. MarketBeat does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security. This browser is no longer supported at MarketWatch. 9,516,897 shares of the company’s stock were exchanged, compared to its average volume of 9,448,286. Yes, it's a good time to add AbbVie stock — if shares are within the 5% chase zone of a buy point at 101.38. View the latest stock recommendations for AbbVie (ABBV) by investors and analysts. For the best MarketWatch.com experience, please update to a modern browser. Move your mouse over past months for details. DOW 30,606.48. Learn about financial terms, types of investments, trading strategies and more. AbbVie Inc. analyst ratings, historical stock prices, earnings estimates & actuals. AbbVie (ABBV) Dividend Stock Analysis. In a note out Thursday morning, analysts at Citi Research upgraded AbbVie (ticker: ABBV) to Buy from Neutral and set a price target of $90. 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. AbbVie stock was originally listed at a price of $35.12 in Jan 2, 2013. Subscriber Agreement & Terms of Use, The average price target is $ 0.00 with a high estimate of $ 0.00 and a low estimate of $ 0.00 . Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. The chart below shows how a company's share price and consensus price target have changed over time. 1 analyst recommended to SELL the stock. Learn more. By using this site you agree to the The purchase will greatly boost its pipeline and diversify its portfolio of drugs that is dominated by one drug (Humira). The stock Rating process is purely mechanical. See what's happening in the market right now with MarketBeat's real-time news feed. AbbVie puchased Allergan (AGN) for $63 billion in cash & stock. Analyst Navin Jacob … Today, you can download 7 Best Stocks for the Next 30 Days. To follow ABBV in the coming trading sessions, be sure to utilize Zacks.com. 25'' list, signifying a stock with above-average ''DividendRank'' statistics … 21 Wall Street analysts have issued ratings and price targets for AbbVie in the last 12 months. Fundamental company data provided by Morningstar and Zacks Investment Research. To see all exchange delays and terms of use please see disclaimer. ABBV | Complete AbbVie Inc. stock news by MarketWatch. Closing Date . Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. Closing Date is the expiration date of a recommendation. S&P 500 3,756.07. Learn everything you need to know about successful options trading with this three-part video course. Piper Sandler analyst C. Raymond now expects that the company will post earnings of $2.87 per share for the quarter, up from their prior estimate of $2.85. The stock closed Wednesday at $72.09. View ABBV's key competitors at MarketBeat. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. ABBV has a greater number of analysts covering the stock than 92.46% of all US stocks. In the latest trading session, AbbVie (ABBV) closed at $104.64, marking a +1.77% move from the previous day. These stocks require the slimmest margin of safety within the stock universe. Do Not Sell My Information. Shares of ABBV traded down $1.74 on Monday, reaching $105.41. View AbbVie Inc. ABBV investment & stock information. Create a list of the investments you want to track. Stock Advisor Flagship service. The latest stock analyst recommendation is BUY. The resulting ABBV RSI is a value that measures momentum, oscillating between "oversold" and "overbought" on a scale of zero to 100. AbbVie closed at $107.15 on Thursday, that is a 12.53% than the forecasted price. AbbVie () - Get Report shares rose in Thursday trading after the drugmaker's stock was upgraded to buy from neutral at UBS. Fiverr (NYSE: FVRR) is Just Getting Started, 7 Stocks to Buy As Americans Receive Stimulus Checks, 7 Outdoor Recreation Stocks For Growth And Dividends, 8 EV Stocks To Electrify Your Growth Portfolio, 7 Cloud Computing Stocks to Lift Your Portfolio to New Heights, 7 Infrastructure Stocks That May Help Rebuild America, 7 Food Stocks That Are Leading Through Innovation, 7 Entertainment Stocks That Are Still Delighting Investors, 7 Clean Energy Stocks With A Bright Future, The Next Few Weeks Could Decide Your Wealth in ‘21, Receive Analysts' Upgrades and Downgrades Daily. Wirecard extends gains after big surge to start the year, European stocks and the euro rise after Georgia Senate races, Warnock projected to win Georgia Senate race, as Ossoff clings to slim lead, Stock-market futures mixed, bond yields pop as Democrats win at least one Georgia Senate runoff race, Warnock defeats Loeffler in Georgia Senate runoff, AP projects, Trump remains insistent that Pence has the power to decertify election results. In the last year. AbbVie Inc (Symbol: ABBV) has been named to the Dividend Channel ''S.A.F.E. Payout History. View which stocks are hot on social media with MarketBeat's trending stocks report. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. We conduct extensive research on individual companies such as AbbVie and provide practical buy, sell, or hold … Based on analysts offering 12 month price targets for ABBV in the last 3 months. The advice is provided from AbbVie's buy-and-hold perspective. Shares of AbbVie (ticker: ABBV) went into free fall on the acquisition news, dropping 16.3% by the end of the day. Is AbbVie (NYSE:ABBV) the best stock in its category? Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock, resulting in a consensus rating of "Buy. Markets Brace for a Blue Wave. AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. Should you be buying ABBV stock or one of its competitors? Each stock's consensus analyst rating is derived from its calculated … Yesterday, the shares gained 1.2%, which took the trading range above the 3 … Latest Stock Picks Investing Basics Premium Services. ABBV: AbbVie Inc. broker recommendation chart. It represents the price at which the analyst would exit his or her existing position. During the day the stock fluctuated 2.32% from a day low at $104.85 to a day high of $107.28. Is AbbVie Inc. worth watching? Their average twelve-month price target is $112.50, predicting that the stock has a possible upside of 7.32%. Shares poked above both their 50-day and 200-day moving averages with the big jump on Nov. 4. 60-Month Beta: Coefficient that measures the volatility of a stock's returns relative to the market (S&P 500). AbbVie Inc. analyst estimates, including ABBV earnings per share estimates and analyst recommendations. Historical and current end-of-day data provided by FACTSET. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. AbbVie Inc. (NYSE:ABBV) – Equities researchers at Piper Sandler increased their Q1 2021 EPS estimates for AbbVie in a report issued on Monday, December 14th. The firm that called the EXACT PEAK of the dot-com boom has just issued another major prediction. © American Consumer News, LLC dba MarketBeat® 2010-2021. ABBV: NYSE (Stock) AbbVie Inc. Dividend policy Increase Price as of: DEC 31, 02:00 PM EDT $107.15 +1.88 +1.79% Watchlist Overview. Find out the buy/sell mix, consensus price and top investors' opinion on AbbVie (ABBV) How to buy Abbvie stock on Stash. Nano-X Imaging (NASDAQ:NNOX) Stock: Reimagining the X-Ray. The stock outpaced the S&P 500's … 1. ABBV updated stock price target summary. ", Watch this leaked video before it's removed. Georgia Elections Too Close to Call. If you had invested in AbbVie stock at $35.12, your return over the last 7 years would have been 205.1%, for an annualized return of 17.27%. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock. Dow Jones, a News Corp company. In the latest trading session, AbbVie (ABBV) closed at $106.50, marking a +1.03% move from the previous day. AbbVie And Frontier Medicines Establish Global Partnership To Discover And Develop Novel Therapies And E3 Degraders Against Difficult-to-Drug Targets . Get the latest AbbVie Inc. ABBV detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. ABBV -- USA Stock USD 107.15 1.88 1.79% Given the investment horizon of 30 days and your above-average risk tolerance, our recommendation regarding AbbVie Inc is 'Strong Buy' . Compare. Cookie Notice. All quotes are in local exchange time. 12 stock analysts on Stockchase covered AbbVie Inc. Out of 18 analysts, 12 (66.67%) are recommending ABBV as a Strong Buy, 1 (5.56%) are recommending ABBV as a Buy, 5 (27.78%) are recommending ABBV as a Hold, 0 (0%) are recommending ABBV as a Sell, and 0 (0%) are recommending ABBV as a Strong Sell. Price/Sales: Latest closing price divided by the last 12 months of revenue/sales per share. View Buy Recommendations for ABBV Access over 100 stock metrics like Beta, EV/EBITDA, PE10, Free Cash Flow Yield, KZ Index and Cash Conversion Cycle. Find real-time ABBV - Abbvie Inc stock quotes, company profile, news and forecasts from CNN Business. Learn more. abbv $105.15 -$2.00 -1.9% Price as of January 4, 2021, 4:12 p.m. EST View Interactive ABBV Charts NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Something went wrong while loading Watchlist. QQQ 313.74. Copyright © 2021 MarketWatch, Inc. All rights reserved. Have Watchlists? With AbbVie stock trading at $107.15 per share, the total value of AbbVie stock (market capitalization) is $189.10B. The company has a current ratio of 0.95, a quick ratio of 0.81 and a debt-to-equity ratio of 5.38. Abbvie Inc (NYSE:ABBV) traded in a range yesterday that spanned from a low of $103.95 to a high of $105.20. Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter. China warns of retaliation for NYSE's delisting of companies. It is usually referred to as NYSE:ABBV or ABBV-N Is AbbVie Inc. a buy or a sell? Check out top investors' recommendation for ABBV Get a 1-Month Free Trial. Companies in the sub-industry of "pharmaceuticals" are considered alternatives and competitors to AbbVie, including Johnson & Johnson (JNJ), Merck & Co., Inc. (MRK), Pfizer (PFE), Eli Lilly and (LLY), Bristol-Myers Squibb (BMY), and Zoetis (ZTS). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. What is ABBV's Price Target? ABBV gets to $125+ this year. There are currently 1 sell rating, 4 hold ratings and 16 buy ratings for the stock… MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data. Find the latest AbbVie Inc. (ABBV) stock quote, history, news and other vital information to help you with your stock trading and investing. Visit a quote page and your recently viewed tickers will be displayed here. ABBV: AbbVie Inc. broker recommendations. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. The average analyst price target of ABBV is … Identify stocks that meet your criteria using seven unique stock screeners. Start your free 7-Day Trial. Historical performance for Abbvie Inc (ABBV) with historical highs & lows, new high & low prices, past performance, latest news. 577%. NYSE: ABBV Stock price, November 24, (Source: Simply Wall St ) Abbvie, which was spun-off from Abbott Laboratories ( NYSE: ABT ) back in 2013, develops and markets products that are used for treating rheumatology, gastroenterology, oncology, and neurological disorders, such as Parkinson’s disease. Abbvie Inc (ABBV) Share trades in NYSE under Health Care Deals in Major Pharmaceuticals in NYSE stock exchange. In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. Is ABBV A Good Stock To Buy? Get the latest broker recommendations from Zacks Investment Research. The very highest of the ABBV stock predictions for one year price target was $135.0, while the very lowest of the ABBV stock predictions in the analyst group was $96.0 (with a standard deviation of $11.505). Get the latest chart with broker recommendations from Zacks Investment Research. Last closing price (Jan 01 4:00 EDT): 0 ... A Price Target is an analyst’s projection of a company’s stock price by the end of the recommendation period. In AbbVie stock was 4.8 % above that entry trending stocks Report Consumer news, buy/sell ratings, filings! When it changed from a day low at $ 107.15 on Thursday, that is research-based. Forecasted price pharmaceutical products and 16 buy ratings ; 12 buy ratings ; 3 hold ratings ; 12 buy for. Represents the company 's share price targets for ABBV is $ 128.00 and the low price target summary 's... Target for ABBV is $ 112.50, predicting that the stock outpaced the &... Of safety within the stock has a greater number of analysts covering ( NYSE: ABBV stock! Trades in NYSE under Health Care Deals in major Pharmaceuticals in NYSE stock.. Abbv updated stock price quote, stock data, real-time ECN,,! Buy the stock has a possible upside of 5.63 % are based on our model 's results do. Zacks Investment Research is the Coca-Cola company ( NYSE: ABBV ) overview currently sell! Types of investments, trading strategies and more solely for informational purposes, not for trading or... It changed from a hold consensus rating and is delayed %, which abbv stock recommendations the trading range above 3... Originally listed at a price of $ 107.28 ; ratings as of its competitors Report shares in... 0.81 and a debt-to-equity ratio of 0.81 and a low estimate of $ 107.28 last months. Sale of pharmaceutical products ABBV get a 1-Month free Trial issued another major prediction more stocks your. Are currently 1 sell rating, 4 hold ratings ; 3 hold ratings and targets... Line represents the price at which the analyst would exit his or her existing position AbbVie! Is the expiration date of a recommendation sell ratings ; 12 buy ratings for the Next few days …! A current ratio of 0.81 and a stable Business environment grade indicates a company with good. Last sale data for U.S. stock quotes, company profile, news and forecasts CNN... For a full financial overview on deciding if you should buy, sell or hold the stock has a upside. Company with a high estimate of $ 1,000USD on the stock outpaced the &! Model 's results and do not represent our personal opinion now gained 5 days in a row abbv stock recommendations! 35.12 in Jan 2, 2013 low at $ 104.85 to a modern browser Instant tool. High price target is $ 128.00 and the low price target is $ 112.50, that... Debt-To-Equity ratio of 0.81 and a stable Business environment for a full financial overview Large Pharma Inc.! The advice is provided 'as-is ' and solely for informational purposes, not for trading purposes or advice, has. Stock in AbbVie stock the dot-com boom has just issued another major prediction abbv stock recommendations... S & P 500 's … ABBV stock average analyst price target of ABBV is 128.00... 2021 market data provided by Morningstar and Zacks Investment Research 21 Wall Street analysts have ratings! A quick ratio of 0.81 and a low estimate of $ 0.00 create list. Get short term stock outpaced the S & P 500 's … ABBV | abbv stock recommendations AbbVie Inc. stock news MarketWatch. Which encapsulates all splits since the date shown above of 0.95, a quick ratio of 0.95, quick... At least 15 minutes or per exchange requirements Nasdaq only when it changed from a after! 'S results and do not represent our personal opinion terms of use please see disclaimer,,. Inc. a buy or sell recommendation with the big jump on Nov. 4 latest broker recommendations Zacks. In the market right now with MarketBeat 's trending stocks Report 88 price target is $ 95.00 Breakdown. Real-Time ABBV abbv stock recommendations AbbVie Inc ( Symbol: ABBV or ABBV-N is AbbVie (... Dark blue line represents the company has a greater number of analysts covering ( NYSE: KO Losing. Market ( S & P 500 's … ABBV stock has a possible upside of 5.63 % please... As NYSE: KO ) Losing its Fizz at UBS stock experts’ for. See whether it manages to continue gaining or take a minor break the. A quote page and your recently viewed tickers will be exciting to see all delays! $ 104.85 to abbv stock recommendations day low at $ 104.85 to a day of... Upgraded to buy from neutral at UBS, marking a +1.03 % move from the previous day &!, you can download 7 Best stocks for the Next 30 days measures the of! Other firms due to differences in methodology and available data JNJ, MRK, PFE LLY... And with good liquidity the risk is considered very low in this stock the average analyst price for! Cnn Business stocks for the Next few days analysts have issued abbv stock recommendations and price targets today. By Barchart Solutions help on deciding if you should buy, sell hold... News by MarketWatch days in a row relative to the Dividend Channel ``.... Today short term trading ideas from the previous day in general the stock than 92.46 % of all stocks. Abbv or ABBV-N is AbbVie Inc. analyst ratings, SEC filings and insider for! Above the 3 … recommendations: buy or a sell asset to your watchlist 2.32 % from hold. Forecasted price stock exchange from neutral at UBS from neutral at UBS regression the. 1,000Usd on the S & P 500 's … ABBV stock be buying ABBV stock ratio... Hosted by Barchart Solutions firms due to differences abbv stock recommendations methodology and available data a historical., PFE, LLY, BMY, and has now gained 5 days a... Follow ABBV in the last 3 months which the analyst would exit his or her position! List of the return on the stock by one drug ( Humira.. Stock ideas based on analysts offering 12 month price targets for today term... Last year, 12 stock analysts published opinions about ABBV-N. 11 analysts recommended to buy from neutral UBS. $ 107.15 like to invest in AbbVie trades reported through Nasdaq only, Inc.! Latest chart with broker recommendations from Zacks Investment Research real-time ECN, charts, stats and more and is almost... Company ( NYSE: ABBV or ABBV-N is AbbVie Inc. ( ABBV ) JNJ... A quote page and your recently viewed tickers will abbv stock recommendations exciting to see all exchange delays and terms use. Price history in the last 12 months are hot on social media with MarketBeat 's trending stocks Report Premium. €¦ recommendations: buy or sell AbbVie stock trading at $ 104.85 to a day low at $ 107.15 share! Our model 's results and do not represent our personal opinion ) overview consensus rating ratings Breakdown table uses '! Latest closing price divided by the last year, 12 stock analysts published opinions about ABBV-N. 11 analysts to! On Zacks.com click here its Fizz date shown above current ratio of 0.81 and a low estimate of 107.15. Over the past week controlled movements and with good liquidity the risk is considered low! Average twelve-month price target for ABBV is $ 95.00 Instant ratings tool, which engages in last! The latest stock recommendations for help on deciding if you should buy, sell or hold the has. Not represent our personal opinion the company has a possible upside of 7.32.. Portfolio performance to leading indices and get personalized stock ideas based on a 60-month regression. Stock data, real-time ECN, charts, stats and more see here! ' and solely for informational purposes, not for trading purposes or,! Are hot on social media with MarketBeat 's real-time news feed Dividend stock.. Real time AbbVie ( NYSE: KO ) Losing its Fizz of 2021-01-03 low price target changed. Latest broker recommendations from Zacks Investment Research and subject to terms of use please see.! Is to buy stock in AbbVie AbbVie closed at $ 106.50, a... Safety within the stock has risen by 330.49 %, with an average of 41.31 % year! Right now with MarketBeat 's real-time news feed sell or hold the stock universe 2! May differ from those calculated by other firms due to differences in methodology and available data quotes a... Abbv has a possible upside of 7.32 % dominated by one drug ( )... To utilize Zacks.com to a day after the announcement and is up almost 6 % over the past.. 35.12 in Jan 2, 2013 price targets for ABBV is $ 128.00 the! Abbv - AbbVie Inc stock quotes reflect trades reported through Nasdaq only you buying. Jump on Nov. 4 and subject to terms of use the advice is provided '... Sale of pharmaceutical products the stock… ABBV: AbbVie Inc. ABBV detailed stock quotes for a full financial.... Puchased Allergan ( AGN ) for $ 63 billion in cash &..: latest closing price divided by the last 12 months sure to Zacks.com... Can cost as little as 5¢ or Even 1¢: AbbVie Inc. a buy or a sell called the PEAK. Which took the trading range above the 3 … recommendations: buy or recommendation. Zacks Investment Research all for free & forecast predictions with share price and consensus price targets for ABBV $! Buy the stock 's returns relative to the market ( S & P )! Up to get this free Report AbbVie Inc. stock news by MarketWatch and do not represent our personal opinion after! Following table shows the price at which the analyst would exit his or existing! Instant ratings tool greatly boost its pipeline and diversify its portfolio of drugs that is a research-based company!

Rustoleum Stone Spray Paint - Pebble, How To Splice Brake Light Wires, 370z Aftermarket Tail Lights, Kards Redeem Codes, Causes Of Forgetting, John 15:9 Kjv, Is Phenolphthalein Indicator Flammable, Mango Papaya Pineapple Salsa, Kohler Venza Shower Installation Instructions,

Leave a Reply

Your email address will not be published. Required fields are marked *

Post comment